A randomised, 52-week, treat-to-target trial comparing insulin determin with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
journal contribution
posted on 2008-05-19, 11:23 authored by Melanie J. DaviesA randomised, 52-week, treat-to-target trial comparing insulin determin with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
History
Citation
Diabetologia, 2008, 51 (3), pp.408-416Published in
DiabetologiaPublisher
Springer VerlagAvailable date
2008-05-19Notes
This is the author's final draft version of the item published as Diabetologia, 51 (3), pp. 408-416Language
enAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC